Delivery Order SPE2DB20D3103-SPE2DB25FP2C5

Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $13,836.26 and a completion date of June 30, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,836.26 delivery order contract is for the supply of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm fixed price type with an ultimate completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $17,792.82 and a performance period through June 30, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TAFINLAR 75 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,139.33 and an ultimate completion date of November 5, 2024. Amerisourcebergen, through its Corporate Office division, will supply this medication to support military treatment facilities and other federal healthcare providers....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with a period of performance through May 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,918.13 Firm Fixed Price delivery order is for the supply of 120 capsules of the drug Tafinlar (50 mg). The contract has a period of performance extending through May 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of 4,568,201,792 units of the medication Tafinlar 75 mg capsules. The contract has an ultimate completion date of June 2, 2025 and was awarded on May 9, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award, valued at $17,792.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FGR57) with a firm fixed-price, non-set-aside contract type. It covers the delivery of 4,567,996,469 units of the prescription medication Tafinlar 75 mg capsule, with a performance period extending through May 13, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product, with a total ceiling value of $6,918.13. The contract is a Firm Fixed Price arrangement with an ultimate completion date of June 18, 2025. This award is not designated as a set-aside contract, indicating open...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP2C5
    Delivery Order

This is a $17,792.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication TAFINLAR 75 MG CAPSULE 120S, with a period of performance through July 10, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 9/16/25, 10:03 AM